Literature DB >> 7378261

Monoamine oxidase inhibitors (MAOI) increase rat brain aromatic amino acid decarboxylase activity.

I C Campbell, D L Murphy, M N Walker, W Lovenberg, D S Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7378261      PMCID： PMC1429990          DOI： 10.1111/j.1365-2125.1980.tb01073.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.

Authors:  J Vetulani; F Sulser
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

3.  Aromatic L-amino acid decarboxylase.

Authors:  W LOVENBERG; H WEISSBACH; S UDENFRIEND
Journal:  J Biol Chem       Date:  1962-01       Impact factor: 5.157

4.  The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain.

Authors:  I C Campbell; D S Robinson; W Lovenberg; D L Murphy
Journal:  J Neurochem       Date:  1979-01       Impact factor: 5.372

5.  Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.

Authors:  D S Robinson; I C Campbell; M Walker; N J Statham; W Lovenberg; D L Murphy
Journal:  Neuropharmacology       Date:  1979-10       Impact factor: 5.250

6.  Short- and long-term lithium administration: effects on the brain's serotonergic biosynthetic systems.

Authors:  S Knapp; A J Mandell
Journal:  Science       Date:  1973-05-11       Impact factor: 47.728
  6 in total
  2 in total

Review 1.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

2.  Elevated dopa decarboxylase activity in living brain of patients with psychosis.

Authors:  J Reith; C Benkelfat; A Sherwin; Y Yasuhara; H Kuwabara; F Andermann; S Bachneff; P Cumming; M Diksic; S E Dyve; P Etienne; A C Evans; S Lal; M Shevell; G Savard; D F Wong; G Chouinard; A Gjedde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.